Once-a-Day Administration of R(+) Propranolol Is Sufficient to Block Vasculogenesis in a Xenograft Model of Infantile Hemangioma
Objective:. Infantile hemangioma (IH) is a benign vascular tumor that occurs in 5% of infants, predominantly in female and preterm neonates. Propranolol is the mainstay of treatment for IH. Given the short half-life of propranolol regarding β-adrenergic receptor inhibition as well as its side effect...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Wolters Kluwer Health/LWW
2024-09-01
|
| Edice: | Journal of Vascular Anomalies |
| On-line přístup: | http://journals.lww.com/10.1097/JOVA.0000000000000096 |